When should expenditure per life saved vary?

Journal of Risk Research

Volumn 5, Issue 3, 2002, Pages 249-263

  Ramsberg, Joakim ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Cost effectiveness; Rawlsian veil of ignorance; Value of life

Indexed keywords

EID: 84937336998     PISSN: 13669877     EISSN: 14664461     Source Type: Journal    
DOI: 10.1080/13669870210122705     Document Type: Article

References (46)

1. Ahearne, J.F. (1993) Integrating risk analysis into public policymaking, Environment 35(2), 16.
2. Brown, M. and Flintor, L. (1993) Cost-effectiveness of breast cancer screening: Preliminary results of a systematic review of the literature, Breast Cancer Research and Treatment 25. 113-18.
3. Cohen, B.L. (1980) Society’s valuation of life saving in radiation protection and other contexts, Health Physics 38. 33-51.
4. Drummond, M. and Stoddart, G. (1995) Assessment of health producing measures across différent sectors, Health Policy 33, 219-31.
5. Drummond, M.F., Torrance, G. and Mason, J. (1993) Cost-effectiveness league tables: more harm than good? Social Science and Medicine 37, 33-40.
6. Fishburn, P.C. and Sarin, R.K. (1991) Dispersive equity and social risk, Managment Science 37. 751-69.
7. Garber, A.M. and Phelps, C.E. (1995) Economie Foundations of Cost-effectiveness Analysis, National Bureau of Economie Research.
8. Garber, A.M. and Phelps, C.E. (1997) Economie Foundations of Cost-effectiveness Analysis, Journal of Health Economies 16,1-31.
9. Gold, M., Siegel, J. and Russel, L. (1996) Cost-effectiveness in Health and Medicine, New York: Oxford University Press.
10. Graham, J.D. (1996) Making sense of risk: an agenda for the Congress, in R. Hahn (ed.) Risks, Costs and Lives Saved: Getting Better Results from Régulation, pp. 181-205, Oxford University Press: New York.
11. Graham, J.D. and Vaupel, J. (1981) The value of life: what différence does it make? Risk Analysis 1, 89-95.
12. Graham, J.D., Corso, P.S., Morris, J.M., Seguigomez, M., and Weinstein, M.C (1998) Evaluating the cost-effectiveness of clinical and public health measures, Annual Revue of Public Health 19. 125-52.
13. Hahn, R.W. (1996) Regulatory reform: what do the government’s numbers tell us?, in R.W. Hanh (ed.) Risks, Costs and Lives Saved. pp. 208-54, Oxford University Press: New York.
14. Hammerton, M., Jones-Lee, M. and Abbott, V. (1982) Equity and public risk: some empirical results. Opérations Research 30. 203-7.
15. Harris, J. (1995) Double jeopardy and the veil of ignorance - a reply, Journal of Médical Ethics 21, 151-57.
16. Harsanyi, J. (1955) Cardinal welfare, individualistic ethics and interpersona! comparisons of utility, Journal ofPolitical Economy 63, 309-21.
17. Jenni, K. (1997) Attributes for Risk Evaluation, Pittsburgh. PA: Carnegie Melon University.
18. Jenni, K. and Loewenstein, G. (1997) Explaining the identifiable victim effect, Journal of Risk and Uncertainty 14. 235-37.
19. Johannesson, M. and Gerdtham, U.-G. (1996) A note on the estimation of equity-efficiency trade- off for QUALYs, Journal of Health Economies 15, 359-68.
20. Jones-Lee, M.W. (1992) Paternalistic altruism and the value of statistical life, The Economie Journa! 102, 80-90.
21. Keeney, R. (1980) Utility functions for equity and public risk. Management Science 26, 345-53.
22. Keeney, R. and Winkler, R. (1985) Evaluating décision stratégies for equity of public risks, Opérations Research 33, 955-70.
23. Keller, R.L. and Sarin, R.K. (1988) Equity in social risk: some empirical observations, Risk Analysis 8, 135-46.
24. Kelman, S. (1981) Cost-benefit analysis: an ethical critique, Régulation Jan/Feb, 33-40.
25. Kishimoto, A. (1997) A comparative analysis of cost-effectiveness of risk réduction policies in Japan, Japanese Journal of Risk Analysis 8, 165-73.
26. Kunreuther, H., Onculer, A. and Slovic, P. (1998) Time insensitivity for protective investments, Journal of Risk and Uncertainty 16, 279-99.
27. Léonard, H.B. and Zeckhauser, R.J. (1986) Cost-benefit analysis applied to risks: its philosophy and legitimacy, in D. MacLean, (ed.) Values at Risk, pp. 31-48, New Jersey: Rowman & Allan- held Publishers.
28. Meltzer, D. (1997) Accounting for future costs in médical cost-effectiveness analysis, Journal of Health Economies 16, 33-64.
29. Morrall, J.F. (1986) A review of the record, Régulation Nov/Dec, 25-34.
30. Pauly, M. (1995) Valuing health care benefits in money terms, in F. Sloan (ed.) Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaeeuticals and Other Médical Devices, pp. 99-124. Cambridge, MA: Cambridge University Press.
31. Pliskin, J., Shepard, D. and Weinstein, M. (1980) Utility functions for life years and health status. Opérations Research 28, 206-24.
32. Pratt, J.W. and Zeckhauser, R.J. (1996) Willingness to pay and the distribution of risk and wealth, Journal of Political Economy 104, 747-63.
33. Ramsberg, J. and Sjôberg, L. (1997) The cost-effectiveness of lifesaving interventions in Sweden, Risk Analysis 17, 467-78.
34. Rawls, J. (1971) A Theory of Justice, Cambridge, MA: Harvard University Press.
35. Schwing, R. (1979) Longevity benefits and costs of reducing various risks, Technological Fore- casting and Social Change 13, 1-23.
36. Siegel, J.E., Weinstein, M.C., Gold, M.R., Kamlet, M.S. and Russell, L.B. (1996) Recommendations of the panel on cost-effectiveness in health and medicine, Journal of the American Médical Association 276(15), 1253-58.
37. Singer, P., McKie, J., Kuhse, H. and Richardson, J. (1995) Double jeopardy and the use of QALYs in health care allocation. Journal of Médical Ethics 21, 144-50.
38. Slovic, P., Lichtenstein, S. and Fischhoff, B. (1984) Modeling the societal impact of fatal accidents, Managment Science 30. 464-74.
39. Slovic, P. (1987) Perception of risk, Science 236, 280-86.
40. Soby, B.A., Bail, D.J. and Ives, D.P. (1993) Safety investment and the value of life and injury, Risk Analysis 13, 365.
41. Sunstein, C.R. (1997) Bad deaths, Journal of Risk and Uncertainty 14, 259-82.
42. Tengs, T., Adams, M.E., Pliskin, J.S., Safran, D.G., Siegal, J.E., Weinstein, M.C. and Graham, J.D. (1995) Five-hundred life-saving interventions and their cost-effectiveness, Risk Analysis 15. 369-91.
43. Tengs, T.O. and Graham, J.D. (1996) The opportunity cost of haphazard social investments in life-saving, in R.W. Hahn, (ed.) Risks, Costs and Lives Saved: Getting Better Results from Régulation, pp. 167-82, New York: Oxford University Press.
44. Weinstein, M., Shepard, D. and Pliskin, J. (1980) The economic value of changing mortality probabilities: a décision theoretic approach. Quarterly Journal of Economies 94, 373-96.
45. Zeckhauser, R. (1975) Procédures for valuing lives, Public Policy 23, 419.
46. Zeckhauser, R. and Shepard, D. (1976) Where now for saving lives? Law and Contemporary Problems 40, 5-45.